Bloodclaw

Bloodclaw Card

Bloodclaw is a 1 Mana Cost Common Paladin Weapon card from the Rastakhan's Rumble set!

Card Text

Battlecry: Deal 5 damage to your hero.

Flavor Text

This weapon – ow! Requires a little – OWW! Finesse.

18 Comments

  1. 2pado
    November 29, 2018 at 11:35 pm

    Along with crystallizer, it makes healing on turn 2 pretty damn consistent, and it also helps you deal with early game minions good card overall

    Reply
  2. Soup And Salad
    November 28, 2018 at 5:01 pm

    Bloodclaw would be so much better of two attack could more consistently kill early game minions, but so many of them have three health.

    “But the battlecry works with Heal Paladin,” a likely response.

    Maybe… This seems to actually have anti-synergy with High Priest Thekal since he wants you to be at or near full health when you play him. Either way, if your early game weapon can’t kill a whole lot of the early game threats it’ll be going against, it’s not going to be great in a control deck. See Woodcutter’s Ax for another example of a card that seems good in control, but its stats killed it.

    If it ends up working anywhere, it might be aggro, but Paladin doesn’t have any weapon buff cards to get much more out of the card.

    Reply
    • Yggdreigon
      November 29, 2018 at 12:35 am

      well i can deal with most 1 and 2 drops. namely flame imp, keleseth, anything paladin plays but 1/3s. It’s pretty much like a “better” candleshot

      Reply
      • Soup And Salad
        November 29, 2018 at 3:31 am

        Some one drops maybe, but your list there is pretty much it.

        Reply
  3. Jed
    November 28, 2018 at 1:56 pm

    You laughed when I crafted the glass knight

    You all laughed

    Who’s laughing now

    Reply
    • Uthoor
      November 28, 2018 at 8:00 pm

      We still laughing at you

      Reply
    • t1mothyPwnz
      November 28, 2018 at 8:07 pm

      glass knight has been in a tier 1 deck for a while now – even paladin

      Reply
      • Jed
        November 28, 2018 at 9:52 pm

        I never said I crafted Genn buddy

        Reply
        • Yggdreigon
          November 29, 2018 at 12:33 am

          you should have

          Reply
  4. MockRock
    November 28, 2018 at 12:21 pm

    Oooookay, Healdin might just actually be a thing now. Between this and Crystallizer you can now damage yourself on turn one and there are a ton of incentives to heal back up.

    Reply
    • Grenga
      November 28, 2018 at 12:57 pm

      Incentive 1, not dieing!

      Reply
      • Ebola Man
        November 28, 2018 at 9:57 pm

        Please learn how to spel.

        Reply
      • Ebola Man
        November 28, 2018 at 9:58 pm

        Healladden is like kill yourself warlock but you have to heal yourself back up again.

        Reply
  5. Cursore1610
    November 28, 2018 at 11:56 am

    Ehy guys, I didn’t wanna say it, but…….. THIS IS CANCER IN ODD PALADIN. I am serious. This is an excellent weapon for an aggro deck that just doesn’t care to be damaged.

    Reply
    • Soup And Salad
      November 28, 2018 at 5:02 pm

      I might agree with you if Paladin had anything to make this into more than a one mana deal four damage card.

      Reply
  6. Omnitarian
    November 28, 2018 at 11:49 am

    A guaranteed way for your healing cards to have value earlygame, while letting you deal with early tokens. But wait, isn’t that what Crystallizer is for?

    Reply
    • Zkool47
      November 28, 2018 at 11:52 am

      Yes, but if you want some sort of aggro heal paladin with ghouls and such, you want consistency since Pally doesn’t have Warlock’s hero power to consistently damage itself.

      Reply
  7. Dr. Roshima
    November 28, 2018 at 11:45 am

    Healadin is gonna be a thing *_*

    Reply

Leave a Comment

Your email address will not be published. Required fields are marked *

Register to keep track of your comments. You can also build and favorite decks!

Comment Policy: Any comments that are overly derogatory will be removed and could result in an account or site ban.